{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:49:20Z","timestamp":1792630160633,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330073"],"award-info":[{"award-number":["82330073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U25A20116"],"award-info":[{"award-number":["U25A20116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373383"],"award-info":[{"award-number":["82373383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402731"],"award-info":[{"award-number":["82402731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Provincial Key Research and Development Program","award":["2024SF2-GJHX-69"],"award-info":[{"award-number":["2024SF2-GJHX-69"]}]},{"name":"Shaanxi Provincial Key Research and Development Program","award":["2025SYS-SYSZD-088"],"award-info":[{"award-number":["2025SYS-SYSZD-088"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"DOI":"10.1186\/s13073-026-01735-6","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:33:05Z","timestamp":1785133985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early and accurate detection of ovarian cancer by profiling cell-free mitochondrial DNA fragmentomics in multi-ethnic population"],"prefix":"10.1186","volume":"18","author":[{"given":"Xinyan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanmin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoquan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renquan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3811-6163","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1735_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.61","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016. https:\/\/doi.org\/10.1038\/nrdp.2016.61.","journal-title":"Nat Rev Dis Primers"},{"key":"1735_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00971-6","author":"M Govindarajan","year":"2020","unstructured":"Govindarajan M, Wohlmuth C, Waas M, Bernardini MQ, Kislinger T. High-throughput approaches for precision medicine in high-grade serous ovarian cancer. J Hematol Oncol. 2020. https:\/\/doi.org\/10.1186\/s13045-020-00971-6.","journal-title":"J Hematol Oncol"},{"key":"1735_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, Desantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018. https:\/\/doi.org\/10.3322\/caac.21456.","journal-title":"CA Cancer J Clin"},{"key":"1735_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.9495","author":"G Caruso","year":"2025","unstructured":"Caruso G, Weroha SJ, Cliby W. Ovarian Cancer: A Review. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.9495.","journal-title":"JAMA"},{"key":"1735_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14070671","author":"AN Stephens","year":"2024","unstructured":"Stephens AN, Hobbs SJ, Kang SW, Oehler MK, Jobling TW, Allman R. ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage. Diagnostics (Basel). 2024. https:\/\/doi.org\/10.3390\/diagnostics14070671.","journal-title":"Diagnostics (Basel)"},{"key":"1735_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010226","author":"N Carreras-Dieguez","year":"2022","unstructured":"Carreras-Dieguez N, Glickman A, Munmany M, Casanovas G, Agusti N, Diaz-Feijoo B, et al. Comparison of HE4, CA125, ROMA and CPH-I for preoperative assessment of adnexal tumors. Diagnostics (Basel). 2022. https:\/\/doi.org\/10.3390\/diagnostics12010226.","journal-title":"Diagnostics (Basel)"},{"key":"1735_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(21)00278-8","author":"Y Gao","year":"2022","unstructured":"Gao Y, Zeng S, Xu X, Li H, Yao S, Song K, et al. Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in china: a retrospective, multicentre, diagnostic study. Lancet Digit Health. 2022. https:\/\/doi.org\/10.1016\/S2589-7500(21)00278-8.","journal-title":"Lancet Digit Health"},{"key":"1735_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2018-000016","author":"KK Gupta","year":"2019","unstructured":"Gupta KK, Gupta VK, Naumann RW. Ovarian cancer: screening and future directions. Int J Gynecol Cancer. 2019. https:\/\/doi.org\/10.1136\/ijgc-2018-000016.","journal-title":"Int J Gynecol Cancer"},{"key":"1735_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/uog.24777","author":"AK Hiett","year":"2022","unstructured":"Hiett AK, Sonek JD, Guy M, Reid TJ. Performance of IOTA simple rules, simple rules risk assessment, adnex model and O-RADS in differentiating between benign and malignant adnexal lesions in north american women. Ultrasound Obstet Gynecol. 2022. https:\/\/doi.org\/10.1002\/uog.24777.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1735_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.44","author":"AK Karam","year":"2010","unstructured":"Karam AK, Karlan BY. Ovarian cancer: the duplicity of CA125 measurement. Nat Rev Clin Oncol. 2010. https:\/\/doi.org\/10.1038\/nrclinonc.2010.44.","journal-title":"Nat Rev Clin Oncol"},{"key":"1735_CR11","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.180499","author":"M Walker","year":"2018","unstructured":"Walker M, Sobel M. Diagnosing ovarian cancer. CMAJ. 2018. https:\/\/doi.org\/10.1503\/cmaj.180499.","journal-title":"CMAJ"},{"key":"1735_CR12","doi-asserted-by":"publisher","DOI":"10.1159\/000501681","author":"E Chacon","year":"2019","unstructured":"Chacon E, Dasi J, Caballero C, Alcazar JL. Risk of ovarian malignancy algorithm versus Risk Malignancy Index-i for preoperative assessment of adnexal masses: a systematic review and meta-analysis. Gynecol Obstet Invest. 2019. https:\/\/doi.org\/10.1159\/000501681.","journal-title":"Gynecol Obstet Invest"},{"key":"1735_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01351-y","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022. https:\/\/doi.org\/10.1186\/s13045-022-01351-y.","journal-title":"J Hematol Oncol"},{"key":"1735_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01588-8","author":"JW Zhu","year":"2022","unstructured":"Zhu JW, Charkhchi P, Akbari MR. Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer. 2022. https:\/\/doi.org\/10.1186\/s12943-022-01588-8.","journal-title":"Mol Cancer"},{"key":"1735_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.09.019","author":"TE Liggett","year":"2011","unstructured":"Liggett TE, Melnikov A, Yi Q, Replogle C, Hu W, Rotmensch J, et al. Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecol Oncol. 2011. https:\/\/doi.org\/10.1016\/j.ygyno.2010.09.019.","journal-title":"Gynecol Oncol"},{"key":"1735_CR16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15249","author":"L Giannopoulou","year":"2017","unstructured":"Giannopoulou L, Chebouti I, Pavlakis K, Kasimir-Bauer S, Lianidou ES. RASSFL1A promoter methylation in high-grade serous ovarian cancer: a direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA. Oncotarget. 2017. https:\/\/doi.org\/10.18632\/oncotarget.15249.","journal-title":"Oncotarget"},{"key":"1735_CR17","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.7.3003","author":"B Wang","year":"2015","unstructured":"Wang B, Yu L, Yang G, Luo X, Huang L. Application of multiplex nested methylated specific PCR in early diagnosis of epithelial ovarian cancer. Asian Pac J Cancer Prev. 2015. https:\/\/doi.org\/10.7314\/apjcp.2015.16.7.3003.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1735_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01440-w","author":"SK Terp","year":"2023","unstructured":"Terp SK, Stoico MP, Dybk\u00e6r K, Pedersen IS. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clin Epigenetics. 2023. https:\/\/doi.org\/10.1186\/s13148-023-01440-w.","journal-title":"Clin Epigenetics"},{"key":"1735_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2017.1334024","author":"MW \u00d8rntoft","year":"2017","unstructured":"\u00d8rntoft MW, Jensen S\u00d8, Hansen TB, Bramsen JB, Andersen CL. Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA. Epigenetics. 2017. https:\/\/doi.org\/10.1080\/15592294.2017.1334024.","journal-title":"Epigenetics"},{"key":"1735_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2023.2275150","author":"MJ Duffy","year":"2024","unstructured":"Duffy MJ, Crown J. Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test? Crit Rev Clin Lab Sci. 2024. https:\/\/doi.org\/10.1080\/10408363.2023.2275150.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1735_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.02.011","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free dna. Ann Oncol. 2020. https:\/\/doi.org\/10.1016\/j.annonc.2020.02.011.","journal-title":"Ann Oncol"},{"key":"1735_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107458","author":"A Campos-Carrillo","year":"2020","unstructured":"Campos-Carrillo A, Weitzel JN, Sahoo P, Rockne R, Mokhnatkin JV, Murtaza M, et al. Circulating tumor DNA as an early cancer detection tool. Pharmacol Ther. 2020. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107458.","journal-title":"Pharmacol Ther"},{"key":"1735_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan2415","author":"J Phallen","year":"2017","unstructured":"Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, et al. Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aan2415.","journal-title":"Sci Transl Med"},{"key":"1735_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/nature22364","author":"C Abbosh","year":"2017","unstructured":"Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature. 2017. https:\/\/doi.org\/10.1038\/nature22364.","journal-title":"Nature"},{"key":"1735_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0393","author":"JE Medina","year":"2025","unstructured":"Medina JE, Annapragada AV, Lof P, Short S, Bartolomucci AL, Mathios D, et al. Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers. Cancer Discov. 2025. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0393.","journal-title":"Cancer Discov"},{"key":"1735_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34981","author":"X Chao","year":"2024","unstructured":"Chao X, Kai Z, Wu H, Wang J, Chen X, Su H, et al. Fragmentomics features of ovarian cancer. Int J Cancer. 2024. https:\/\/doi.org\/10.1002\/ijc.34981.","journal-title":"Int J Cancer"},{"key":"1735_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/uog.29314","author":"A Vanderstichele","year":"2025","unstructured":"Vanderstichele A, Ceusters J, Fischerova D, Testa AC, Froyman W, Landolfo C, et al. Added value of cell-free DNA over clinical and ultrasound information for diagnosing ovarian cancer. Ultrasound Obstet Gynecol. 2025. https:\/\/doi.org\/10.1002\/uog.29314.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1735_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03074-w","author":"Y Van der Pol","year":"2023","unstructured":"Van der Pol Y, Moldovan N, Ramaker J, Bootsma S, Lenos KJ, Vermeulen L, et al. The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection. Genome Biol. 2023. https:\/\/doi.org\/10.1186\/s13059-023-03074-w.","journal-title":"Genome Biol"},{"key":"1735_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz105","author":"C Yin","year":"2019","unstructured":"Yin C, Li DY, Guo X, Cao HY, Chen YB, Zhou F, et al. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis. Ann Oncol. 2019. https:\/\/doi.org\/10.1093\/annonc\/mdz105.","journal-title":"Ann Oncol"},{"key":"1735_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.12.017","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou K, Guo S, Wang Y, Ji X, Yuan Q, et al. NGS-based accurate and efficient detection of circulating cell-free mitochondrial DNA in cancer patients. Mol Ther Nucleic Acids. 2021. https:\/\/doi.org\/10.1016\/j.omtn.2020.12.017.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1735_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2020.09.005","author":"K Zhou","year":"2020","unstructured":"Zhou K, Mo Q, Guo S, Liu Y, Yin C, Ji X, et al. A novel next-generation sequencing-based approach for concurrent detection of mitochondrial DNA copy number and mutation. J Mol Diagn. 2020. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.09.005.","journal-title":"J Mol Diagn"},{"key":"1735_CR32","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0527","author":"Y Liu","year":"2025","unstructured":"Liu Y, Peng F, Wang S, Jiao H, Zhou K, Guo W, et al. Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma. Clin Mol Hepatol. 2025. https:\/\/doi.org\/10.3350\/cmh.2024.0527.","journal-title":"Clin Mol Hepatol"},{"key":"1735_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333533","author":"S Wang","year":"2025","unstructured":"Wang S, Peng F, Dang M, Jiao H, Zhang H, Zhou K, et al. Early detection of colorectal cancer using aberrant circulating cell-free mitochondrial DNA fragmentomics. Gut. 2025. https:\/\/doi.org\/10.1136\/gutjnl-2024-333533.","journal-title":"Gut"},{"key":"1735_CR34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202411-2247OC","author":"F Peng","year":"2026","unstructured":"Peng F, Wang S, Jiao H, Dang M, Zhang H, Zhou K, et al. Accurate and early diagnosis of non-small cell lung cancer using aberrant fragmentomic features of circulating cell-free mitochondrial DNA. Am J Respir Crit Care Med. 2026. https:\/\/doi.org\/10.1164\/rccm.202411-2247OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1735_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00163-6","author":"Y Liu","year":"2024","unstructured":"Liu Y, Peng F, Wang S, Jiao H, Dang M, Zhou K, et al. Aberrant fragmentomic features of circulating cell-free mitochondrial DNA as novel biomarkers for multi-cancer detection. EMBO Mol Med. 2024. https:\/\/doi.org\/10.1038\/s44321-024-00163-6.","journal-title":"EMBO Mol Med"},{"key":"1735_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231912041","author":"R Zhang","year":"2022","unstructured":"Zhang R, Siu MKY, Ngan HYS, Chan KKL. Molecular Biomarkers for the Early Detection of Ovarian Cancer. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231912041.","journal-title":"Int J Mol Sci"},{"key":"1735_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0201-z","author":"Y Tian","year":"2015","unstructured":"Tian Y, Wang C, Cheng L, Zhang A, Liu W, Guo L, et al. Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women. J Ovarian Res. 2015. https:\/\/doi.org\/10.1186\/s13048-015-0201-z.","journal-title":"J Ovarian Res"},{"key":"1735_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.02.003","author":"K Matsuo","year":"2019","unstructured":"Matsuo K, Machida H, Mandelbaum RS, Grubbs BH, Roman LD, Sood AK, et al. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: difference in characteristics and outcomes. Gynecol Oncol. 2019. https:\/\/doi.org\/10.1016\/j.ygyno.2019.02.003.","journal-title":"Gynecol Oncol"},{"key":"1735_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100877","author":"J Ju","year":"2024","unstructured":"Ju J, Zhao X, An Y, Yang M, Zhang Z, Liu X, et al. Cell-free DNA end characteristics enable accurate and sensitive cancer diagnosis. Cell Rep Methods. 2024. https:\/\/doi.org\/10.1016\/j.crmeth.2024.100877.","journal-title":"Cell Rep Methods"},{"key":"1735_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101349","author":"N Moldovan","year":"2024","unstructured":"Moldovan N, van der Pol Y, van den Ende T, Boers D, Verkuijlen S, Creemers A, et al. Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis. Cell Rep Med. 2024. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101349.","journal-title":"Cell Rep Med"},{"key":"1735_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88866-5","author":"V Ungerer","year":"2021","unstructured":"Ungerer V, Bronkhorst AJ, Van den Ackerveken P, Herzog M, Holdenrieder S. Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-88866-5.","journal-title":"Sci Rep"},{"key":"1735_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0189-0","author":"KDP Dorayappan","year":"2018","unstructured":"Dorayappan KDP, Wanner R, Wallbillich JJ, Saini U, Zingarelli R, Suarez AA, et al. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3\/Rab proteins. Oncogene. 2018. https:\/\/doi.org\/10.1038\/s41388-018-0189-0.","journal-title":"Oncogene"},{"key":"1735_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96552-9","author":"A Suri","year":"2021","unstructured":"Suri A, Perumal V, Ammalli P, Suryan V, Bansal SK. Diagnostic measures comparison for ovarian malignancy risk in epithelial ovarian cancer patients: a meta-analysis. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-96552-9.","journal-title":"Sci Rep"},{"key":"1735_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104222","author":"L Liang","year":"2022","unstructured":"Liang L, Zhang Y, Li C, Liao Y, Wang G, Xu J, et al. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer. EBioMedicine. 2022. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104222.","journal-title":"EBioMedicine"},{"key":"1735_CR45","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 3.2024. Available online with free registration. Last accessed July 16, 2024."},{"key":"1735_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003295","author":"G Funston","year":"2020","unstructured":"Funston G, Hamilton W, Abel G, Crosbie EJ, Rous B, Walter FM. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study. PLoS Med. 2020. https:\/\/doi.org\/10.1371\/journal.pmed.1003295.","journal-title":"PLoS Med"},{"key":"1735_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133151","author":"J Vara","year":"2022","unstructured":"Vara J, Manzour N, Chacon E, Lopez-Picazo A, Linares M, Pascual MA, et al. Ovarian adnexal reporting data system (O-RADS) for classifying adnexal masses: a systematic review and meta-analysis. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14133151.","journal-title":"Cancers (Basel)"},{"key":"1735_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052830","author":"L Xun","year":"2021","unstructured":"Xun L, Zhai L, Xu H. Comparison of conventional, doppler and contrast-enhanced ultrasonography in differential diagnosis of ovarian masses: a systematic review and meta-analysis. BMJ Open. 2021. https:\/\/doi.org\/10.1136\/bmjopen-2021-052830.","journal-title":"BMJ Open"},{"key":"1735_CR49","doi-asserted-by":"publisher","unstructured":"Guo X, Gong Z, Li Z, Sun T, Fu Y, Jiao H et al. Early and accurate detection of ovarian cancer by profiling cell-free mitochondrial DNA fragmentomics in multi-ethnic population. Sci Data Bank. https:\/\/doi.org\/10.57760\/sciencedb.42929","DOI":"10.57760\/sciencedb.42929"},{"key":"1735_CR50","doi-asserted-by":"publisher","unstructured":"Guo X, Gong Z, Li Z, Sun T, Fu Y, Jiao H et al. Early and accurate detection of ovarian cancer by profiling cell-free mitochondrial DNA fragmentomics in multi-ethnic population. Github. https:\/\/doi.org\/10.5281\/zenodo.21335675","DOI":"10.5281\/zenodo.21335675"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01735-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01735-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01735-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:30:03Z","timestamp":1792629003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01735-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1735"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01735-6","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Xijing and Tangdu Hospitals of Fourth Military Medical University (FMMU) (permission number: KY20183331-1; Date issued: 2018-03-08), Fudan University Shanghai Cancer Center (FUSCC) (permission number: 050432-4-2108*; Date issued: 2021-08-09) and Tumor Hospital Affiliated to Xinjiang Medical University (permission number: S-2024113; Date issued: 2024-07-24). Written informed consent was obtained from all participants. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent to publish data collected in the study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"163"}}